Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
Am J Physiol Gastrointest Liver Physiol
; 317(4): G508-G517, 2019 10 01.
Article
in En
| MEDLINE
| ID: mdl-31460789
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Non-alcoholic Fatty Liver Disease
/
Liraglutide
/
Hypoglycemic Agents
Type of study:
Etiology_studies
Limits:
Animals
Language:
En
Journal:
Am J Physiol Gastrointest Liver Physiol
Journal subject:
FISIOLOGIA
/
GASTROENTEROLOGIA
Year:
2019
Type:
Article
Affiliation country:
France